The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
Viral dynamics in hepatitis B virus infection.
Open accessAbstract
Treatment of chronic hepatitis B virus (HBV) infections with the reverse transcriptase inhibitor lamivudine leads to a rapid decline in plasma viremia and provides estimates for crucial kinetic constants of HBV replication. We find that in persistently infected patients, HBV particles are cleared from the plasma with a half-life of approximately 1.0 day, which implies a 50% daily turnover of the free virus population. Total viral release into the periphery is approximately 10(11) virus particles per day. Although we have no direct measurement of the infected cell mass, we can estimate the turnover rate of these cells in two ways: (i) by comparing the rate of viral production before and after therapy or (ii) from the decline of hepatitis B antigen during treatment. These two independent methods give equivalent results: we find a wide distribution of half-lives for virus-producing cells, ranging from 10 to 100 days in different patients, which may reflect differences in rates of lysis of infected cells by immune responses. Our analysis provides a quantitative understanding of HBV replication dynamics in vivo and has implications for the optimal timing of drug treatment and immunotherapy in chronic HBV infection. This study also represents a comparison for recent findings on the dynamics of human immunodeficiency virus (HIV) infection. The total daily production of plasma virus is, on average, higher in chronic HBV carriers than in HIV-infected patients, but the half-life of virus-producing cells is much shorter in HIV. Most strikingly, there is no indication of drug resistance in HBV-infected patients treated for up to 24 weeks.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Infectious Diseases of Humans: Dynamics and Control
Anderson, R. M., & May, R. M. (1991) · doi:10.1093/oso/9780198545996.001.0001 · Cited by 6,179
Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection
Ho, D. D., Neumann, A. U., Perelson, A. S., Chen, W., Leonard, J. M., & Markowitz, M. (1995) · Nature · doi:10.1038/373123a0 · Cited by 4,267
HIV-1 Dynamics in Vivo: Virion Clearance Rate, Infected Cell Life-Span, and Viral Generation Time
Perelson, A. S., Neumann, A. U., Markowitz, M., Leonard, J. M., & Ho, D. D. (1996) · Science · doi:10.1126/science.271.5255.1582 · Cited by 3,531
Viral dynamics in human immunodeficiency virus type 1 infection
Wei, X., Ghosh, S. K., Taylor, M. E., Johnson, V. A., Emini, E. A., Deutsch, P., Lifson, J. D., Bonhoeffer, S., Nowak, M. A., Hahn, B. H., et al. (1995) · Nature · doi:10.1038/373117a0 · Cited by 3,260
Self-citationHall, A. J. (1992) · Transactions of the Royal Society of Tropical Medicine and Hygiene · doi:10.1016/0035-9203(92)90276-i · Cited by 2,131
HIV Population Dynamics in Vivo: Implications for Genetic Variation, Pathogenesis, and Therapy
Coffin, J. M. (1995) · Science · doi:10.1126/science.7824947 · Cited by 1,981
Diseases of the Liver and Biliary System
(2001) · Wiley eBooks · doi:10.1002/9780470986820 · Cited by 1,825
THE MOLECULAR BIOLOGY OF THE HEPATITIS B VIRUSES
Ganem, D., & Varmus, H. E. (1987) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.56.070187.003251 · Cited by 1,084
A Preliminary Trial of Lamivudine for Chronic Hepatitis B Infection
Dienstag, J. L., Perrillo, R. P., Schiff, E. R., Bartholomew, M., Vicary, C., & Rubin, M. (1995) · New England Journal of Medicine · doi:10.1056/nejm199512213332501 · Cited by 800
Bertoletti, A., Sette, A., Chisari, F. V., Penna, A., Levrero, M., Carli, M. D., Fiaccadori, F., & Ferrari, C. (1994) · Nature · doi:10.1038/369407a0 · Cited by 540
Cited by
Hepatitis C Viral Dynamics in Vivo and the Antiviral Efficacy of Interferon-α Therapy
Neumann, A. U., Lam, N. P., Dahari, H., Gretch, D. R., Wiley, T. E., Layden, T. J., & Perelson, A. S. (1998) · Science · doi:10.1126/science.282.5386.103 · Cited by 2,113
Hepatocellular carcinoma pathogenesis: from genes to environment
Farazi, P. A., & DePinho, R. A. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1934 · Cited by 1,979
Seeger, C., & Mason, W. S. (2000) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.64.1.51-68.2000 · Cited by 1,451
Domingo, E., Sheldon, J., & Perales, C. (2012) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.05023-11 · Cited by 1,009
Modelling viral and immune system dynamics
Perelson, A. S. (2002) · Nature Reviews Immunology · doi:10.1038/nri700 · Cited by 955
Molecular biology of hepatitis B virus infection
Seeger, C., & Mason, W. S. (2015) · Virology · doi:10.1016/j.virol.2015.02.031 · Cited by 866
Kinetics of Influenza A Virus Infection in Humans
Baccam, P., Beauchemin, C., Macken, C. A., Hayden, F. G., & Perelson, A. S. (2006) · Journal of Virology · doi:10.1128/jvi.01623-05 · Cited by 756
Hepatitis B Virus Resistance to Nucleos(t)ide Analogues
Zoulim, F., & Locarnini, S. (2009) · Gastroenterology · doi:10.1053/j.gastro.2009.08.063 · Cited by 706
Effects of extended lamivudine therapy in Asian patients with chronic hepatitis B
Liaw, Y., Leung, N. W. Y., Chang, T., Guan, R., Tai, D., Ng, K., Chien, R., Dent, J., Roman, L., Edmundson, S., et al. (2000) · Gastroenterology · doi:10.1053/gast.2000.8559 · Cited by 689
Virus dynamics and drug therapy
Bonhoeffer, S., May, R. M., Shaw, G. M., & Nowak, M. A. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.13.6971 · Cited by 632
Self-citationMathematical analysis of delay differential equation models of HIV-1 infection
Nelson, P. W., & Perelson, A. S. (2002) · Mathematical Biosciences · doi:10.1016/s0025-5564(02)00099-8 · Cited by 463
Viral dynamics in vivo: limitations on estimates of intracellular delay and virus decay.
Herz, A. V., Bonhoeffer, S., Anderson, R. M., May, R. M., & Nowak, M. A. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.14.7247 · Cited by 440
Self-citationMathematical and Computational Challenges in Population Biology and Ecosystems Science
Levin, S. A., Grenfell, B., Hastings, A., & Perelson, A. S. (1997) · Science · doi:10.1126/science.275.5298.334 · Cited by 382
Nomenclature for antiviral-resistant human hepatitis B virus mutations in the polymerase region
Stuyver, L. (2001) · Hepatology · doi:10.1053/jhep.2001.22166 · Cited by 382
Jones, J., Shepherd, J., Baxter, L., Gospodarevskaya, E., Hartwell, D., Harris, P., & Price, A. (2009) · Health Technology Assessment · doi:10.3310/hta13350 · Cited by 357
Rapid Emergence of Protease Inhibitor Resistance in Hepatitis C Virus
Rong, L., Dahari, H., Ribeiro, R. M., & Perelson, A. S. (2010) · Science Translational Medicine · doi:10.1126/scitranslmed.3000544 · Cited by 355
Song, B.-C., Suh, D. J., Lee, H. C., Chung, Y.-H., & Lee, Y. S. (2000) · Hepatology · doi:10.1053/jhep.2000.16665 · Cited by 336
Hepatitis C virus resistance to protease inhibitors
Halfon, P., & Locarnini, S. (2011) · Journal of Hepatology · doi:10.1016/j.jhep.2011.01.011 · Cited by 305
Suspène, R., Guétard, D., Henry, M., Sommer, P., Wain-Hobson, S., & Vartanian, J.-P. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0408223102 · Cited by 304
Hepatitis B virus morphogenesis
Bruss, V. (2007) · World Journal of Gastroenterology · doi:10.3748/wjg.v13.i1.65 · Cited by 289
Moraleda, G., Saputelli, J., Aldrich, C. E., Averett, D., Condreay, L., & Mason, W. S. (1997) · Journal of Virology · doi:10.1128/jvi.71.12.9392-9399.1997 · Cited by 263
Naturally Occurring Variants of Hepatitis B Virus
Günther, S., Fischer, L., Pult, I., Sterneck, M., & Will, H. (1999) · Advances in Virus Research · doi:10.1016/s0065-3527(08)60298-5 · Cited by 255
Biphasic clearance kinetics of hepatitis B virus from patients during adefovir dipivoxil therapy
Tsiang, M., Rooney, J. F., Toole, J. J., & Gibbs, C. S. (1999) · Hepatology · doi:10.1002/hep.510290626 · Cited by 242
Metadata
- Authors
- Nowak, M. A., Bonhoeffer, S., Hill, A. M., Boehme, R., Thomas, H. C., & McDade, H.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 1996-04-30
- Volume
- 93
- Issue
- 9
- Pages
- 4398-4402
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W1991592276
- Cited by
- 1,045
- References
- 23
- FWCI
- 22.00
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.